By Pam Belluck More than three-quarters of Americans diagnosed with long Covid were not sick enough to be hospitalized for their initial infection, a new analysis of tens of thousands of private insurance claims reported on Wednesday. The researchers...
By Qin Liu, et al. originally published January 26, 2022 in BMJ Gut. Abstract Background Long-term complications after COVID-19 are common, but the potential cause for persistent symptoms after viral clearance remains unclear. Objective To investigate...
by Robert Thomas et al. Originally published March 16, 2022 Download PDF Browse Figures Citation Export Abstract Gut microflora dysbiosis affects the majority of individuals after COVID-19, contributing to both gastro-intestinal (GI) and non-GI symptoms. Natural...
Some research has shown that lingering Covid symptoms are more prevalent in people in their 30s and 40s — when workers are often in the prime of their careers. How will companies support employees with debilitating symptoms that can linger for months or even years...
BY JOSEPH CHOI Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus. Ill effects from the condition can include fatigue, pain, neurological...
Early anecdotes about Paxlovid’s effects on long COVID are intriguing, but no one’s testing them in clinical trials yet. By Katherine J. Wu In the two years since she caught the coronavirus, 38-year-old Jessica McGovern has cycled through “well over 100 drugs,...
By James Gallagher Image caption,Neil Robinson has had long Covid for two years The initial emergency of Covid may feel like it's over, but thousands of people are still suffering from ongoing symptoms known as long Covid. So are we any closer to understanding the...
By Stephen Ditmore Acute COVID-19 Clinical Trials There are four clinical trials of Low Dose Naltrexone (LDN) as an acute COVID-19 therapeutic in the United States, two of which are currently recruiting. Statera BioPharma (formerly Cytocom), which calls its...
After the National Institutes of Health (NIH) awarded the USC-affiliated Children’s Hospital Los Angeles (CHLA) an $8.3 million grant in January, a team of experts is preparing to kick off a study to assess the long-term effects of COVID-19 (long COVID) in...
— Cognitive tests show "notable reduction" in memory ability by Judy George Seven in 10 people, most of whom said they had long COVID, experienced concentration and memory problems months after acute SARS-CoV-2 infection and many performed worse than their peers on...
by Laura Pole, RN, MSN, Nurse Practitioner Just in my little circle of friends, several of whom got COVID in the last 3 months, are now having very troubling symptoms, some of which are impacting their ability to work and basically function well. Take my friend,...
— Both groups face scrutiny over long COVID recommendations by Jennifer Henderson IncellDx, a company that's marketing a diagnostic and treatment plan for long COVID, says it's not at all associated with the Front Line COVID-19 Critical Care Alliance (FLCCC) after...
Individuals, providers urge New York to take nation-leading role in fight against long COVID By Bethany Bump It was Halloween 2020 when the first member of the Hogan family got sick. First came excruciating headaches for Rebekah Hogan, a nurse at St. Peter’s...
By Josh Keller BRAINInflammation and low oxygen levels may cause cognitive problems.LUNGSEarly evidence of oxygen limitations.CIRCULATORY SYSTEMVascular damage and blood clots may trigger fatigue.IMMUNE SYSTEMAutoantibodies or viral remnants may set off a chain...
— FLCCC promotes 20 therapies: like "throwing spaghetti against the wall," one expert says by Jennifer Henderson As patients with long COVID scour the internet desperate for relief, physicians are concerned they may stumble upon an unproven treatment plan touted by a...